News

Filter

Current filters:

deCODE GeneticsMetabolics

101 to 110 of 97524 results

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

16-01-2015

US specialty drugmaker Depomed has entered into a definitive agreement to acquire the US rights to the…

DepomedGrunenthalJanssenJohnson & JohnsonLicensingNeurologicalNucyntaPharmaceuticalUSA

AstraZeneca unit in deal with Omnis Pharma for oncolytic viruses in immuno-oncology

15-01-2015

Anglo-Swedish pharma major AstraZeneca’s biologics R&D subsidiary MedImmune has entered into a licensing…

AstraZenecaBiotechnologyLicensingMedImmuneOmnis PharmaceuticalsOncology

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

Baby boomers and BRICS will boost industry in 2015, report predicts

Baby boomers and BRICS will boost industry in 2015, report predicts

15-01-2015

The biggest trends in the health care industry in 2014 are expected to develop further in 2015, according…

GlobalHealthcareInternational relationsMarketResearch.comPharmaceutical

High turnover and protocol noncompliance continue to plague the global investigative site landscape, says Tufts CSDD

15-01-2015

Global clinical trial performance and efficiency are hampered by high turnover and noncompliance among…

ManagementPharmaceuticalResearchUSA

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

15-01-2015

The pharmaceutical industry faces a number of unique challenges when recruiting staff. Unlike in many…

BoardroomGlobalHireRightPharmaceuticalPharmacology

Eric Terhaerdt appointed senior vice president of global development operations at Astellas

Eric Terhaerdt appointed senior vice president of global development operations at Astellas

15-01-2015

Japanese drug major Astellas Pharma has appointed Eric Terhaerdt as senior vice president of global development…

AstellasAstellas PharmaBoardroomEric TerhaerdtJapanPharmaceutical

FDA committee votes to not recommend Ferring’s desmopressin

FDA committee votes to not recommend Ferring’s desmopressin

15-01-2015

The US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has…

desmopressinFerring PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

101 to 110 of 97524 results

Back to top